Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 444-450

  Dietrich, W Dalton ^a   Busto, Raul ^a   Bethea, John R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Anti inflammatory agents; Cytokines; Hypothermia; IL 10; Neuronal damage; Rats; Temperature

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FOREBRAIN; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHERMIA; ISCHEMIA; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPERATURE;

EID: 0032837804     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7115     Document Type: Article

References (47)

1. Banati R. B., Rothe G., Valet G., Kreutzberg G. W. Respiratory burst in brain macrophages: A flow cytometric study on cultured rat microglia. Neuropathol. Appl. Neurobiol. 17:1991;223-230.
2. Barbieri I., Brusa R., Basudev H., Casati C., Grilli M. Neuroprotective action of interleukin-10 in mouse primary neuronal cultures. J. Neurosci. Abstr. 1998;568.13.
3. Berkman N., John M., Roesems G., Jose P. J., Barnes P. J., Chung K. F. Inhibition of macrophage inflammatory protein-1 α expression by IL-10. J. Immunol. 155:1995;4412-4418.
4. Bethea J. R., Castro M., Keane R. W., Lee T. T., Dietrich W. D., Yezierski R. P. Traumatic spinal cord injury induces nuclear factor-κB activation. J. Neurosci. 18:1998;3251-3260.
5. Bethea J. R., Castro M., Briceno C., Gomez F., Marcillo A. E., Yezierski R. P., Dietrich W. D. Systemically administered interleukin-10 (IL-10) attenuates injury induced inflammation and is neuroprotective following traumatic spinal cord injury. Soc. Neurosci. Abstr. 24:1998;1446.
6. Bethea J. R., Acosta M. C., Briceno C., Gomez F., Tantama M. C., Jagid J. R., Marcillo A. E., Dietrich W. D. Systemically administered interleukin-10 (IL-10) attenuates tumor necrosis factor (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) expression and is neuroprotective following traumatic spinal cord injury in rats. J. Neurotrauma. 1998.
7. Boje K. M., Arora P. K. Microglial produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
8. Borish L. IL-10: Evolving concepts. J. Allergy Clin. Immunol. 101:1998;293-297.
9. Busto R., Dietrich W. D., Globus M. Y.-T., Martinez E., Valdes I., Scheinberg P., Ginsberg M. D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
10. Chao C., Hu S., Molitor T. W., Shaskan E. G., Peterson P. K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
11. Chopp M., Zhang R. L., Chen H., Li Y., Jiang N., Rusche J. R. Postischemic administration of an anti-mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 25:1994;869-876.
12. Coimbra C. G., Wieloch T. Moderate hypothermia mitigates neuronal damage when initiated several hours following transient cerebral ischemia. Acta Neuropathol. 87:1994;325-331.
13. Coimbra C., Drake M., Boris-Moeller F., Wieloch T. Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug: Evidence for chronic encephalopathic processes following ischemia. Stroke. 27:1996;1578-1585.
14. Colbourne F., Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654:1994;265-272.
15. Colbourne F., Corbett D. Delayed postischemic hypothermia: A six month survival study using behavioral and histological assessments of neuroprotection. J. Neurosci. 15:1995;7250-7260.
16. Colbourne F., Sutherland G., Corbett D. Postischemic hypothermia: A critical appraisal, with implications for clinical treatment. Mol. Neurobiol. 14:1997;171-201.
17. Colton C. A., Gilbert D. L. Production of superoxide anion by a CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
18. Crisi G. M., Santambrogio L., Hochwald G. M., Smith S. R., Carlino J. A., Thorbecke G. J. Staphylococcal enterotoxin B and tumor-necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10. Eur. J. Immunol. 25:1995;30.
19. Dietrich W. D., Busto R., Alonso O., Globus M. Y.-T., Ginsberg M. D. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 13:1993;541-549.
20. Dietrich W. D., Lin B., Globus M. Y.-T., Green E. J., Ginsberg M. D., Busto R. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;960-968.
21. Dietrich W. D. Temperature and brain injury: Therapeutic hypothermia. Bar P. R., Beal M. F. Neuroprotection in CNS Diseases. 1997;253-268 Dekker, New York.
22. Feuerstein G. Z., Liu T., Barone F. C. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-α Cerebrovasc. Brain Metab. Rev. 6:1994;341-360.
23. Frei K., Lins H., Schwerdel C., Fontana A. Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:1994;2720-2728.
24. Gehrmann J., Bonnekoh P., Miyazawa T., Hossman K.-A., Kreutzberg G. W. Immunocytochemical study of an early microglial activation in ischemia. J. Cereb. Blood Flow Metab. 12:1992;257-269.
25. Gheng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA. 91:1994;8602-8606.
26. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
27. Giulian D. Reactive glia as rivals in regulating neuronal survival. Glia. 7:1993;102-110.
28. Green E. J., Dietrich W. D., van Dijk F., Busto R., Markgraf C. G., McCabe P. M., Ginsberg M. D., Schneiderman N. Protective effects of neural hypothermia on behavior following global cerebral ischemia in rats. Brain Res. 580:1992;197-204.
29. Green E. J., Pazos A. J., Dietrich W. D., McCabe P. M., Schneiderman N., Lin B., Busto R., Globus M. Y.-T., Ginsberg M. D. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res. 702:1995;145-152.
30. Hayward R., Nossuli T. O., Scalia R., Lefer A. M. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur. J. Pharmacol. 334:1997;157-163.
31. Ikonomidou C., Mosinger J. L., Olney J. W. Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant rats. Brain Res. 487:1989;184-187.
32. Knoblock S. M., Faden A. I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 153:1998;143-151.
33. Koedel U., Bernatowicz A., Frei K., Fontana A., Pfister H.-W. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:1996;5185-5191.
34. Lavine S. D., Hofman F. M., Zlokovic B. V. Circulating antibody against tumor necrosis factor alpha protects rat brain from reperfusion injury. J. Cereb. Blood Flow Metab. 18:1998;52-58.
35. Li H., Buchan A. M. Progressive loss of hippocampal CA1 neurons following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 15:1995;5246.
36. Mertz P. M., DeWitt D. L., Stetler-Stevenson W. G., Wah L. M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J. Biol. Chem. 269:1994;21322-21329.
37. Minamisawa H., Smith M. L., Siesjo B. K. The effect of mild hyperthermia and hypothermia on brain damage following 5, 10 and 15 minutes of forebrain ischemia. Ann. Neurol. 28:1990;26-33.
38. Morioka T., Kaleehua A. N., Streit W. The microglial reaction in the dorsal hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 11:1991;966-973.
39. Piani D., Frei K., Do K. Q., Cuenod M., Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:1991;159-162.
40. Rothwell N. J., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. Am. Soc. Clin. Invest. 100:1997;2648-2652.
41. Rott O., Fleisher B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
42. Sanna A., Pflug B., Colangelo A. M., Mocchetti I. Interleukin-10 prevents glutamate-induced apoptosis in cerebellar granule cells. J. Neurosci. Abstr. 1998.
43. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
44. Smith M.-L., Bendek G., Dahlgren N., Rosen I., Wieloch T., Siesjo B. K. Models for studying long-term recovery following forebrain ischemia in the rat. 2. A two vessel occlusion model. Acta Neurol. Scand. 69:1984;385-401.
45. Spera P. A., Ellison J. A., Feuerstein G. Z., Barone F. C. IL-10 reduces brain injury following focal stroke. Neurosci. Letters. 251:1998;189-192.
46. Valtysson J., Hillered L., Andine P., Hagberg H., Dorsson L. Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation. Acta Neurochir. (Wien). 129:1994;58-63.
47. Zilles K. The Cortex of the Rat: A Stereotaxic Atlas. 1985;Springer-Verlag, Berlin.